trial · primary record
NG2 and DLL3 CAR-T cells
Melanoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Number of patients with adverse events. |
| Registry ID | NCT07193966 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:09.217Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07193966
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.